Effect of G17DT in Patients With Stage II/III Colorectal Cancer
NCT02518373
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Colorectal Cancer
Interventions
BIOLOGICAL:
G17DT
DRUG:
Omeprazole
Sponsor
Cancer Advances Inc.